(Q24186075)

2

0 references

Esther J van Zuuren

object named as

Esther J van Zuuren

1

1 reference

ORCID Public Data File 2021

author name string

Adriana Lavrijsen

3

0 references

Robin Christensen

4

0 references

Bernd Arents

Cochrane Database of Systematic Reviews

5

0 references

publication date

11 March 2016

0 references

published in

0 references

cites work

Oral H1 antihistamines as monotherapy for eczema

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Topical pimecrolimus for eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Oral evening primrose oil and borage oil for eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Dietary exclusions for established atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Dietary supplements for established atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Atopic dermatitis: a disease of altered skin barrier and immune dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Atopic eczema or atopiform dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Probiotics for atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Specific allergen immunotherapy for the treatment of atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

FTIR studies show lipophilic moisturizers to interact with stratum corneum lipids, rendering the more densely packed

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Topical corticosteroid phobia in patients with atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients' perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Epidemiological characteristics of methicillin-resistant Staphylococcus aureus isolates from children with eczematous atopic dermatitis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Epidermal barrier dysfunction in atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Topical tacrolimus for atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Investigating international time trends in the incidence and prevalence of atopic eczema 1990-2010: a systematic review of epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Atopic dermatitis and the atopic march revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Lipid abnormalities and lipid-based repair strategies in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Psychological and educational interventions for atopic eczema in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

How atopic is atopic dermatitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

New insights into the epidemiology of childhood atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Leukotriene receptor antagonists for atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Chinese herbal medicine for atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles-continuous outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Early life risk factors for atopic dermatitis in Ethiopian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Allergic characteristics of urban schoolchildren with atopic eczema in Ghana

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Point and period prevalences of eczema in rural and urban schoolchildren in Ghana, Gabon and Rwanda

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Complementary and alternative medicine treatments for atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Morbidity and cost of atopic eczema in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Effects of systemic immunosuppressive therapies for moderate-to-severe eczema in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Environmental factors, parental atopy and atopic eczema in primary-school children: a cross-sectional study in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Atopic dermatitis: new insights and opportunities for therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Role of Topical Emollients and Moisturizers in the Treatment of Dry Skin Barrier Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Effect of moisturizers on epidermal barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Different strategies for using topical corticosteroids for established eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Use of emollients in dry-skin conditions: consensus statement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

New emollient with topical corticosteroid-sparing effect in treatment of childhood atopic dermatitis: SCORAD and quality of life improvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Atopic eczema: what's new?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

House dust mite reduction and avoidance measures for treating eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Atopic dermatitis: global epidemiology and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Prevalence of community-acquired methicillin-resistant Staphylococcus aureus and antibiotic resistance in patients with atopic dermatitis in Porto Alegre, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Stratum corneum moisturization at the molecular level: an update in relation to the dry skin cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Molecular basis for stratum corneum maturation and moisturization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Guidelines for treatment of atopic eczema (atopic dermatitis) part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Guidelines for treatment of atopic eczema (atopic dermatitis) Part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

The connection between in vitro water uptake and in vivo skin moisturization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

What are the best outcome measurements for atopic eczema? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

A pilot study of emollient therapy for the primary prevention of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Validation of treatment escalation as a definition of atopic eczema flares

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Practical methods for incorporating summary time-to-event data into meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

The important role of stratum corneum lipids for the cutaneous barrier function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

No high level evidence to support the use of oral H1 antihistamines as monotherapy for eczema: a summary of a Cochrane systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Clinical practice. Atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

How epidemiology has challenged 3 prevailing concepts about atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Is eczema really on the increase worldwide?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

The role of atopic sensitization in flexural eczema: Findings from the International Study of Asthma and Allergies in Childhood Phase Two

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

How well do questionnaires perform compared with physical examination in detecting flexural eczema? Findings from the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Two

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

The importance of free fatty acid chain length for the skin barrier function in atopic eczema patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Loss-of-Function Mutations in the Filaggrin Gene Lead to Reduced Level of Natural Moisturizing Factor in the Stratum Corneum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

Effects of petrolatum on stratum corneum structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

7 January 2021

Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

7 January 2021

The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

7 January 2021

Tests of statistical hypotheses concerning several parameters when the number of observations is large

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

7 January 2021

Validation of the U.K. diagnostic criteria for atopic dermatitis in a population setting. U.K. Diagnostic Criteria for Atopic Dermatitis Working Party

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

7 January 2021

Use of an emollient as a steroid-sparing agent in the treatment of mild to moderate atopic dermatitis in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

7 January 2021

Hydrophilic and lipophilic moisturizers have similar penetration profiles but different effects on SC water distribution in vivo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012119

7 January 2021